Microglial senescence

CNS and Neurological Disorders - Drug Targets

Volumn 12, Issue 6, 2013, Pages 763-767

  Streit, Wolfgang J ^a   Xue, Qing Shan ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Microglial activation; Microglial dystrophy; Neurodegenerative disease; Neuroinflammation

Indexed keywords

CD68 ANTIGEN; INTERLEUKIN 1; MESSENGER RNA; TAU PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUTISM; BLOOD BRAIN BARRIER; DEGENERATIVE DISEASE; DEPRESSION; DOWN SYNDROME; HISTOPATHOLOGY; HUMAN; HUNTINGTON CHOREA; HYPOTHERMIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEUKOCYTE; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROGLIA; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; PARKINSON DISEASE; PHAGOCYTOSIS; PROTEIN EXPRESSION; SCHIZOPHRENIA; SENESCENCE; WOUND HEALING;

ANIMALS; BRAIN; CELL AGING; HUMANS; MICROGLIA; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES;

EID: 84888028504     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/18715273113126660176     Document Type: Article

References (26)

1. Choi, H.A.; Badjatia, N.; Mayer, S.A. Hypothermia for acute brain injury--mechanisms and practical aspects. Nat. Rev. Neurol., 2012, 8, 214-222.
2. Streit, W.J., Semple-Rowland, S.L., Hurley, S.D., Miller, R.C., Popovich, P.G., and Stokes, B.T. Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp. Neurol., 1998, 152, 74-87.
3. Gehrmann, J.; Banati, R.B. Microglial turnover in the injured CNS: activated microglia undergo delayed DNA fragmentation following peripheral nerve injury. J. Neuropathol. Exp. Neurol., 1995, 54, 680-688.
4. Jones, L.L.; Banati, R.B.; Graeber, M.B.; Bonfanti, L.; Raivich, G.; Kreutzberg, G.W. Population control of microglia: does apoptosis play a role?. J. Neurocytol., 1997, 26, 755-770.
5. Dijkstra, C.D.; Dopp, E.A.; Joling, P.; Kraal, G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology, 1985, 54, 589-599.
6. Graeber, M.B.; Lopez-Redondo, F.; Ikoma, E.; Ishikawa, M.; Imai, Y.; Nakajima, K.; Kreutzberg, G.W.; Kohsaka, S. The microglia/ macrophage response in the neonatal rat facial nucleus following axotomy. Brain Res., 1998, 813, 241-253.
7. Graeber, M.B.; Li, W.; Rodriguez, M.L. Role of microglia in CNS inflammation. FEBS Lett., 2011, 585, 3798-3805.
8. Arvanitakis, Z.; Grodstein, F.; Bienias, J.L.; Schneider, J.A.; Wilson, R.S.; Kelly, J.F.; Evans, D.A.; Bennett, D.A. Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology. Neurology, 2008, 70, 2219-2225.
9. Martin, B.K.; Szekely, C.; Brandt, J.; Piantadosi, S.; Breitner, J.C.; Craft, S.; Evans, D.; Green, R.; Mullan, M. Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib. Arch. Neurol., 2008, 65, 896-905.
10. Hardy, J.; Selkoe, D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science, 2002, 297, 353-356.
11. Castellani, R.J.; Smith, M.A. Compounding artefacts with uncertainty, and an amyloid cascade hypothesis that is 'too big to fail'. J. Pathol., 2001, 224, 147-152.
12. Streit, W.J.; Braak, H.; Xue, Q.S.; Bechmann, I. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Acta Neuropathol., 2009, 118, 475-485.
13. Xue, Q.S.; Streit, W.J. Microglial pathology in Down syndrome. Acta Neuropathol., 2011, 122, 455-466.
14. Streit, W.J.; Sammons, N.W.; Kuhns, A.J.; Sparks, D.L. Dystrophic microglia in the aging human brain. Glia, 2004, 45, 208-212.
15. Streit, W.J. Microglial activation and neuroinflammation in Alzheimer's disease: a critical examination of recent history. Front. Aging Neurosci., 2010, 2, 22.
16. McGeer, P.L.; Itagaki, S.; Tago, H.; McGeer, E.G. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci. Lett., 1987, 79, 195-200.
17. Craggs, R.I.; Webster, H.D. Ia antigens in the normal rat nervous system and in lesions of experimental allergic encephalomyelitis. Acta Neuropathol., 1985, 68, 263-272.
18. Hayes, G.M.; Woodroofe, M.N.; Cuzner, M.L. Microglia are the major cell type expressing MHC class II in human white matter. J. Neurol. Sci., 1987, 80, 25-37.
19. Arriagada, P.V.; Growdon, J.H.; Hedley-Whyte, E.T.; Hyman, B.T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology, 1992, 42, 631-639.
20. Nelson, P.T.; Braak, H.; Markesbery, W.R. Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship. J. Neuropathol. Exp. Neurol., 2009, 68, 1-14.
21. Grober, E.; Dickson, D.; Sliwinski, M.J.; Buschke, H.; Katz, M.; Crystal, H.; Lipton, R.B. Memory and mental status correlates of modified Braak staging. Neurobiol. Aging, 1999, 20, 573-579.
22. Riley, K.P.; Snowdon, D.A.; Markesbery, W.R. Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Ann. Neurol., 2002, 51, 567-577.
23. Braak, H.; Del Tredici, K. The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathol., 2011, 121, 171-181.
24. Streit, W.J. Microglia and Alzheimer's disease pathogenesis. J. Neurosci. Res., 2004, 77, 1-8.
25. Giulian, D.; Haverkamp, L.J.; Yu, J.H.; Karshin, W.; Tom, D.; Li, J.; Kirkpatrick, J.; Kuo, L.M.; Roher, A.E. Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J. Neurosci., 1996, 16, 6021-6037.
26. Lopes, K.O.; Sparks, D.L.; Streit, W.J. Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity. Glia, 2008, 56, 1048-1060.